Objectives Successful vaccination is key to overcoming the COVID-19 pandemic.
Immunosuppressive medication is known to potentially compromise vaccination responses …

Objective The development of sufficient COVID-19 vaccines has been a big breakthrough in
fighting the global SARS-CoV-2 pandemic. However, vaccination effectiveness can be …

Objectives To better understand the factors that influence the humoral immune response to
vaccination against SARS-CoV-2 in patients with immune-mediated inflammatory diseases …

COVID-19 vaccines are of great importance in reducing SARS-CoV-2 infection and severe
cases. Patients with autoimmune inflammatory rheumatic diseases (AIIRDs) have been …

Objectives The effect of different modes of immunosuppressive therapy in autoimmune
inflammatory rheumatic diseases (AIRDs) remains unclear. We investigated the impact of …

Abstract The coronavirus disease 2019 (COVID-19) pandemic has caused more than 100
million infections and 2 million deaths worldwide. In up to 20% of cases, COVID-19 infection …

In view of the COVID-19 pandemic, there is an unmet clinical need for the guidelines on
vaccination of patients with autoimmune inflammatory rheumatic diseases (AIIRD). This …

Objectives A third COVID-19 vaccination is recommended for immunosuppressed patients.
However, data on immunogenicity and safety of a third COVID-19 vaccination in patients …

The COVID-19 pandemic has occupied the world agenda since December 2019. With no
effective treatment yet, vaccination seems to be the most effective method of prevention …

Patients with a systemic autoimmune rheumatic disease (AIRD) are vulnerable to SARS Cov-
2 infection. Vaccination against this infection can prevent the patients from developing …